Page last updated: 2024-11-06

mepiprazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

mepiprazole: psychotropic agent; tranquilizer in schizophrenia; possible chronobiotic agent for therapy in circadian rhythm desynchronization; RN given refers to parent cpd; RN for EMD 16923 with MF unknown: 52499-69-1 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID71897
CHEMBL ID2106537
CHEBI ID134701
SCHEMBL ID355534
SCHEMBL ID355535
MeSH IDM0052097

Synonyms (25)

Synonym
mepiprazole
h-4007
emd-16923
CHEBI:134701
1-(3-chlorophenyl)-4-[2-(5-methyl-1h-pyrazol-3-yl)ethyl]piperazine
CHEMBL2106537
1-(m-chlorophenyl)-4-(2-(5-methylpyrazol-3-yl)ethyl)piperazine
mepiprazolum [inn-latin]
emd 16923
mepiprazol
unii-977bal0nr7
1-(3-chlorphenyl)-4-(2-(5-methyl-3-pyrazolyl)ethyl)piperazin
mepiprazol [inn-spanish]
20326-12-9
mepiprazole [inn:ban]
mepiprazolum
977bal0nr7 ,
mepiprazole [inn]
mepiprazole [mi]
SCHEMBL355534
SCHEMBL355535
DTXSID30174223
DB09197
FT-0731890
Q6817816

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The BK dose-response curve was shifted to the right by topical indomethacin."( A novel model of pain sensation using superfused gastrosplenic omentum preparation of anesthetized rats.
Katori, M; Majima, M; Yang, SJ, 2008
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
piperazines
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (83.33)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.41 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (42.86%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (57.14%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]